Dr Kevin Tay

Expertise in Uncommon Skin Cancers: Melanoma

Dr Tay’s interest in melanoma dates back to his oncology training in the United States, where he was involved in early clinical trials of ipilimumab during an important period in the development of immunotherapy for advanced melanoma. This experience gave him early exposure to an emerging treatment approach that would subsequently help transform the treatment landscape for advanced melanoma. It also contributed to his longstanding clinical interest in melanoma and other uncommon skin cancers.

Expertise in Lymphoma & Haematologic Malignancies: Rare Lymphomas

Dr Tay developed significant research experience in lymphoma during his oncology training in the United States. He spent two years at the National Institutes of Health (NIH) conducting translational lymphoma research under the mentorship of Dr Wyndham Wilson, Dr Louis Staudt and Dr Elaine Jaffe. His research spanned several lymphoma subtypes, including diffuse large B-cell lymphoma, peripheral T-cell lymphoma, NK/T-cell lymphoma and primary mediastinal large B-cell lymphoma, giving him exposure to the biological diversity and complexity of these diseases. This experience continues to inform his clinical interest in lymphoma and other haematologic malignancies.

Being diagnosed with rare cancers does not mean no hope and no good treatments available. Our understanding of rare cancers has advanced considerably, especially with precision molecular diagnostics available. We can personalise therapies based on the individual’s molecular profile and identify the appropriate treatment options.

I would always recommend a treatment approach to my patients similar to how I would treat myself or a loved one in the same predicament. With rare and complex cancers, it is particularly important to understand exactly what we are dealing with, reviewing the pathology and molecular information carefully, and then bringing together the appropriate expertise when necessary. Ultimately, I want every patient to feel that we have explored every reasonable avenue and that they have a team of specialists walking beside them throughout their cancer journey.

Dr Tay also treats a broad range of cancers in addition to the rare cancer areas highlighted on this page. His broader oncology experience includes breast and gynaecological cancers, blood cancers including myeloma and leukaemia, soft tissue and bone sarcomas, brain cancer, other skin cancers and HIV-related cancers.

To learn more about his broader clinical experience, qualifications and areas of expertise, visit Dr Kevin Tay’s full profile.